Westminster, CA – July 31 2019 – BioLargo, Inc. (OTCQB:BLGO),
developer of sustainable science and technologies and a full-service
environmental engineering company, today announced that
its Canadian subsidiary BioLargo Water, Inc. has commenced a pre-commercial demonstration
pilot that will utilize the company’s Advanced Oxidation System (AOS) to treat
captured stormwater in Southern California at BioLargo’s Westminster,
California facility. The pilot’s goal is to demonstrate the technical and
economic feasibility of deploying the AOS to enable stormwater treatment and
reuse, an important and emerging water management application in the US and
Canada. The pilot project is supported in part by research and development
funding of to up to $189,000 from the National Research Council of Canada Industrial
Research Assistance Program (NRC IRAP).
BioLargo Water will collaborate on the project with Richard
Watson & Associates, Inc. and Carollo Engineers, Inc. Richard Watson has
been active in stormwater quality management since 1990 and currently consults
to three watershed management groups in Los Angeles County. Carollo Engineers,
a leading environmental engineering firm providing cost-effective, innovative,
and reliable water treatment solutions, will provide engineering and water
treatment validation for the project.
The goals of this demonstration pilot will focus on the
efficacy of the AOS to treat captured stormwater to water reuse standards. The
pilot will also help establish the capital and operating costs of the AOS in
this application, a crucial step before potential commercial pilot clients and
paying customers would consider the technology in this industrial setting.
BioLargo Water President Dr. Richard Smith commented on the
news, “This pre-commercial demonstration pilot represents a pivotal moment for our
company and for the AOS technology. It’s an opportunity to show the world that
the AOS can provide high-performance and cost-effective treatment of captured
stormwater and play a big role in the more than $4 billion stormwater use
market.”
 |
| Photo Source: www.medium.com |
BioLargo CEO Dennis Calvert commented, “Stormwater capture,
treatment, and use is an important and emerging water management market in the
United States, particularly in California where voters in Los Angeles county
recently passed ‘Measure W’ to provide $300M annually to pay for projects,
infrastructure, and programs to capture, treat, and use stormwater and urban
runoff. BioLargo is eager to demonstrate that the AOS is capable of helping
solve challenges in this area that is so important to California, the United States,
and globally.”
With this announcement, BioLargo is now conducting three
pre-commercial pilots for its AOS technology: a poultry processing wastewater
pilot in Northern Alberta, Canada; a brewery wastewater pilot in Southern
California; and this stormwater pilot. These pilots represent a critical step
toward commercialization, as they will provide crucial real-life technical and
economic data required for the technology’s adoption by future customers, and
will produce the case study data required to accelerate market adoption of this
novel and potentially disruptive technology.
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and
environmental engineering company driven by a mission to "make life
better" by delivering robust, sustainable solutions for a broad range of
industries and applications, with a focus on clean water, clean air, and
advanced wound care. We develop and commercialize disruptive technologies by
providing the capital, support, and expertise to expedite them from
"cradle" to "maturity" (www.biolargo.com).
Our engineering division features experienced professional engineers dedicated
to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne
Clean Industrial Odor Eliminator (www.cupridyne.com),
which eliminates the odor-causing compounds and VOCs rather than masking them,
and is now winning over leading companies in the solid waste handling and
wastewater industries and other industries that contend with malodors and VOCs.
Our subsidiary BioLargo Water (www.biolargowater.ca)
develops the Advanced Oxidation System "AOS," a disruptive industrial
water treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective
and gentle solutions for chronic infected wounds to promote infection control
and regenerative tissue therapy.
Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540
x2
Safe Harbor Act
This press release includes “forward-looking statements”
within the meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Actual results may differ from
expectations, estimates and projections and, consequently, you should not rely
on these forward-looking statements as predictions of future events. Words such
as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,”
“intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “continue,” and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements involve
significant risks and uncertainties that could cause the actual results to
differ materially from the expected results.
